Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease.

Source:http://linkedlifedata.com/resource/pubmed/id/21904459

Download in:

View as

General Info

PMID
21904459